Cancer clinical trials in the region Auvergne-Rhône-Alpes

462 currently recruiting clinical trials

Looking for clinical trials?

Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:

Create your account
Copy-paste your latest medical report
Our AI-based assistant does the rest for you

Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:

Create your account

Phase 2 Lymphoma #NCT06558604 #2023-506706-40-00

[GLOASIS] Étude de phase II évaluant le GLOFITAMAB en association avec le VENETOCLAX plus le ZANUBRUTINIB ou le VENETOCLAX seul chez des sujets atteints d'un lymphome à cellules du manteau à haut risque non traité ou récidivant/réfractaire - Cohorte C

B cell lymphoma Mantel cell lymphoma Early (stage I and II) Disseminated (stage III and IV) None > 60 ml/min 50-60 ml/min 30-50 ml/min None Systemic Treatment-Naive

Bispecific T-cell engager antibodies

13 recruiting sites

The Lymphoma Academic Research Organisation (LYSARC)

Phase 2 Lymphoma #NCT06558604 #2023-506706-40-00

B cell lymphoma Mantel cell lymphoma Early (stage I and II) Disseminated (stage III and IV) None > 60 ml/min 50-60 ml/min 30-50 ml/min 1 2 3 or more Targeted therapy

Bispecific T-cell engager antibodies

13 recruiting sites

The Lymphoma Academic Research Organisation (LYSARC)

Phase 2 Colon cancer Rectal cancer #NCT07150403 #2025-522108-26-00

Chimiothérapie de deuxième ligne par doublet (FOLFOX ou FOLFIRI) associée au fruquintinib versus chimiothérapie par doublet (FOLFOX ou FOLFIRI) associée au bévacizumab dans le cancer colorectal métastatique

Adenocarcinoma Metastatic 1 Chemotherapy Targeted therapy

MSI/dMMR Systemic Treatment-Naive

9 recruiting sites

Fédération Francophone de Cancérologie Digestive

Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT04602377 #2024-515310-40-01

Ajout de pembrolizumab à la chimiothérapie standard chez les patients atteints de cancer de l'ovaire à petites cellules de type hypercalcémique

Other ovarian cancer Localized Locally Advanced Metastatic None Systemic Treatment-Naive Systemic Treatment-Naive

Immunotherapy Chemotherapy Immunotherapy Chemotherapy

6 recruiting sites

ARCAGY/ GINECO GROUP

Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT05872204

Abémaciclib et létrozole chez les patientes atteintes d'un cancer de l'ovaire rare à récepteurs d'œstrogènes positifs

Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Other ovarian cancer Serous low grade carcinoma (LGSOC) Endometrioid carcinoma Stromal cells and sex cords tumor HR Positive Locally Advanced Metastatic 1 2 3 or more Chemotherapy Hormone therapy

Systemic Treatment-Naive

6 recruiting sites

Universitaire Ziekenhuizen KU Leuven

Phase 2 Ovarian / Fallopian tubes / Peritoneum cancer #NCT06690775 #2024-517190-24-00

CATALINA-2 : Une étude clinique du TORL-1-23 dans le cancer de l'ovaire résistant au platine.

Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Locally Advanced Metastatic Other mutation 1 2 3 or more Recurrence within 6 months after platinum-based tr... Chemotherapy

Systemic Treatment-Naive

3 recruiting sites

TORL Biotherapeutics, LLC

Phase 2 Endometrial cancer #NCT06906341 #2024-517432-21-00

[BELLA] RELACORILANT en association avec différents schémas thérapeutiques chez les patientes atteintes de cancers gynécologiques

Bras C

Stage III Stage IV Locally Advanced Metastatic 1 2 Immunotherapy Chemotherapy

Systemic Treatment-Naive

6 recruiting sites

Corcept Therapeutics

Phase 2 Lymphoma #NCT05283720 #2023-505347-38-00

Etude de l'innocuité et la tolérabilité de l'EPCORITAMAB en association avec des agents antinéoplasiques chez les participants adultes atteints d'un lymphome non hodgkinien - Bras 1 à 4

B cell lymphoma Large B cell lymphoma Indolent transformed lymphoma None 1 2 3 or more

Bispecific T-cell engager antibodies

8 recruiting sites

Abbvie

Phase 2 Breast cancer #NCT04965766 #2023-505923-30-00

[ICARUS-BREAST] Étude du PATRITUMAB DERUXTECAN (U3-1402) dans le cancer du sein localement avancé ou métastatique inopérable

HER2 Negative HR Positive Locally Advanced Metastatic Chemotherapy Targeted therapy Hormone therapy

10 recruiting sites

Gustave Roussy, Campus du cancer, Grand Paris

Phase 2 Rectal cancer #NCT04749108 #2021-000414-41

[GRECCAR14] Étude évaluant la prise en charge personnalisée du cancer du rectum localement avancé

Adenocarcinoma Locally Advanced None Systemic Treatment-Naive

27 recruiting sites

Institut du Cancer de Montpellier - Val d'Aurelle